A Randomized Open Label Phase II Trial Comparing BIBW2992 Plus Simvastatin With BIBW2992 Plus Best Supportive Care in Previously Treated Patients With Advanced (Stage IIIB/IV) Non-adenocarcinomatous Non-small Cell Lung Cancer (NSCLC).
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Afatinib; Simvastatin
- Indications Non-small cell lung cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 20 Oct 2010 Status changed from not yet recruiting to recruitingas reported by ClinicalTrials.gov.
- 20 Oct 2010 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.